 | • レポートコード：MRC2103A340 • 出版社/出版日：Mordor Intelligence / 2021年2月15日 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：消費財 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料では、世界のライフサイエンス産業用防護服市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場インサイト、市場動向、製品別（スーツ/カバーオール、手袋、エプロン、フェイスマスク・帽子、保護メガネ・クリーンルームゴーグル）分析、種類別（使い捨て式、再利用可能式）分析、用途別（クリーンルーム用衣類、放射線防護、細菌/ウイルス保護、化学的保護、その他）分析、地域別分析、競争状況、投資分析、市場の将来の項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場インサイト ・市場動向 ・世界のライフサイエンス産業用防護服市場規模：製品別（スーツ/カバーオール、手袋、エプロン、フェイスマスク・帽子、保護メガネ・クリーンルームゴーグル） ・世界のライフサイエンス産業用防護服市場規模：種類別（使い捨て式、再利用可能式） ・世界のライフサイエンス産業用防護服市場規模：用途別（クリーンルーム用衣類、放射線防護、細菌/ウイルス保護、化学的保護、その他） ・世界のライフサイエンス産業用防護服市場規模：地域別 ・競争状況 ・投資分析 ・市場の将来 |
The Protective Clothing Market for Life Sciences Industry was valued at USD 2842 million in 2020 and expected to reach USD 4063 million by 2026 and grow at a CAGR of 6.1% over the forecast period (2021 – 2026). Generally, the relative growth of the life sciences segments is linked to the expenditure of the regional markets for healthcare and innovation.
– The life sciences sector can be broadly categorized into three major segments (based on the applications of protective clothing), – pharmaceutical, biotechnology, and medical. Generally, the relative growth of the life sciences segments is linked to the expenditure of regional markets for healthcare and innovation. In the current market scenario, almost all economies, especially developing economies, are increasing their spending on healthcare and innovation.
– Owing to the emerging manufacturing activity in the pharmaceuticals sector, the demand for protective clothing to be used in the preclinical and early-phase drugs and in production environments are expected to experience increased demand. For example, the Chinese market is vibrant with preclinical and early-phase drugs, and is a growing hub of biotech activity and creates opportunity in the region.
– According to the World Health Organization, medical devices comprise all the tools used in the diagnosis or treatment of ailments, ranging from surgical scissors to pacemakers and complex scanning equipment. Medical device equipment is classified into Class I, Class IIA, Class IIB, and Class III, based on the risk involved in handling the material, which makes the demand recurring from this sector in the life sciences industry. All these factors complement the need for market studied.
– Amid the ongoing outbreak of COVID-19, the pandemic has created an unprecedented proliferation for the demand for protective clothing across the world. The public is scrambling for the mandated masks, whereas healthcare workers are struggling to get the safe care in the face of PPE (Personal Protective Equipment) shortage, including, masks, N-95 respirators, goggles, face shields, gowns or coveralls, gloves, etc.
– In April 2020, Vietnam Textile and Apparel Association (VITAS) has mentioned that, the Vietnamese garment manufacturers has quickly shifted its production line for manufacturing additional medical face masks and protective clothing for export to countries that have impacted hard. The association has also mentioned that it is following the tandards and regulations set by US and European Union (EU) markets.
Key Market Trends
Outbreak of Covid-19 will Boost the Demand for PPE Kits
– Based on WHO modelling, an estimated 89 million medical masks are required for the COVID-19 response each month. For examination gloves, that figure goes up to 76 million, while international demand for goggles stands at 1.6 million per month.
– Since January, 3M has doubled production of N95 respirators to 1.1 billion per year at its global manufacturing facilities, including in the U.S., Asia and Europe. 3M will double its capacity again to 2 billion per year within the next 12 months. The company produced more than 1 million N95 respirators/day in the U.S. for healthcare workers (in April 2020).
– India, which was not manufacturing even a single personal protective equipment (PPE) kit, is now producing 2.06 lakh PPE kits daily within two months after the coronavirus outbreak.
– With the increasing cases of COVID-19, the requirement of personal protective equipment (PPE) has crossed the adequate supply, which results in a major shortage in some geographies. As per Mordor Intelligence analysis, shortages of PPE kits and medical supplies will exist for years without government bodies’ firm strategic steps.
– Furthermore, institutions across the globe have donated a significant number of PPE products, which further helped society fight with the virus. For instance, in March 2020, the Massachusetts Institute of Technology (MIT) has donated thousands of Personal Protective Equipment (PPE) kits from across campus. To respond to the unprecedented requirement, a cross-campus team at MIT was working to solicit and gather any extra, unopened PPE products from laboratories at MIT.
Asia-Pacific to Witness the Highest Growth
– Asia-Pacific is emerging as one of the fastest-growing markets, aided by proactive measures taken by the regional governments of countries, like India and China, to develop local manufacturing and innovation centers.
– Jiangsu, a Chinese province, has one of the largest biopharmaceutical and medical device industries in China. Major pharma companies and CMOs such as WuXi AppTec (Shanghai, China), Siegfried Holding AG (Zofingen, Switzerland), and AstraZeneca (Cambridge, UK) have manufacturing facilities in Jiangsu.
– Asia-Pacific region offers an emerging scope for medical tourism, since people are traveling to these countries due to the increase in quality services and technological advancement in the healthcare and medical sectors. According to the Medical Tourism Association, the cost saving is 90% when a patient gets treated in a developing country, rather than his/ her home (developed) country.
– According to the Microsoft Asia News Center, Asia-Pacific’s healthcare organizations track business improvements of up to 21% due to digital transformation.
– Moreover, in August 2019, DuPont Safety and Construction launched the Kevlar and Tychem hand protection portfolio of glove and sleeve solutions in the Indian market. The solution is designed to increase workplace protection in hazardous environments from automotive applications to sanitation, manufacturing, and subsurface oil and gas exploration. The company is offering reliable hand protection solutions to meet the latest industry standards.
Competitive Landscape
The Protective Clothing Market for Life Sciences Industry is consolidated in nature. Major companies, like E. I. DuPont de Nemours and Company, Kimberly Clark Corporation, Ansell Limited, and 3M Company, design and manufacture clothes to protect medical personnel from serious workplace injuries.
– April 2019 – Honeywell acquired Norcross Safety products LLC., a manufacturer of personal protective equipment (PPE) for approximately USD 1.2 billion. The acquisition is expected to provide Honeywell a complete platform in a fragmented, global segment that is expected to yield substantial growth opportunities. Investing in Norcross allows Honeywell to fully participate in the broad and highly regulated industrial safety marketplace.
– March 2019 – Ansell launched the MICROFLEX MidKnight XTRA, a nitrile exam glove tested against both fentanyl and gastric acid to simulate real-world overdose situations. The gloves are designed for first responders as well as a range of workers who may come into contact with fentanyl or its analogues during the course of their work, including corrections officers, healthcare professionals, laboratory technicians, and janitorial staff.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET INSIGHTS
4.1 Market Overview
4.2 Industry Attractiveness – Porter’s Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitutes
4.2.5 Intensity of Competitive Rivalry
4.3 Industry Value Chain Analysis
5 MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Strict Regulatory Standards Pertaining to Patient Safety
5.1.2 Growth in Biotechnology and Healthcare Spending
5.2 Market Restraints
5.2.1 Increased Demand for Outsourcing and Automation in Pharmaceutical Manufacturing
5.3 Assessment of Impact of COVID-19 on the Industry
6 MARKET SEGMENTATION
6.1 Products
6.1.1 Suits/ Coveralls
6.1.2 Gloves
6.1.3 Aprons
6.1.4 Facemasks and Hats
6.1.5 Protective Eyewear and Cleanroom Goggles
6.1.6 Footwear and Overshoes
6.1.7 Wipes
6.1.8 Other Products
6.2 Type
6.2.1 Disposable
6.2.2 Reusable
6.3 Application
6.3.1 Cleanroom Clothing
6.3.1.1 Pharmaceutical
6.3.1.2 Biotechnology
6.3.1.3 Medical
6.3.2 Radiation Protection
6.3.3 Bacterial/ Viral Protection
6.3.4 Chemical Protection
6.3.5 Other Applications
6.4 Geography
6.4.1 North America
6.4.1.1 United States
6.4.1.2 Canada
6.4.2 Europe
6.4.2.1 United Kingdom
6.4.2.2 Germany
6.4.2.3 France
6.4.2.4 Rest of the Europe
6.4.3 Asia Pacific
6.4.3.1 China
6.4.3.2 Japan
6.4.3.3 India
6.4.3.4 Rest of the Asia Pacific
6.4.4 Rest of the World (Latin America and Middle East and Africa)
7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 E. I. DuPont De Nemours and Company
7.1.2 Kimberly Clark Corporation
7.1.3 Ansell Limited
7.1.4 3M Company
7.1.5 Honeywell International Inc.
7.1.6 Lakeland Industries Inc.
7.1.7 Irudek Group
7.1.8 Berkshire Corporation
7.1.9 Kappler Inc.
7.1.10 Tronex International Inc.
8 INVESTMENT ANALYSIS
9 FUTURE OF THE MARKET